NFKB1 and B-cell non-Hodgkin lymphoma: At ∼18 months, B cells acquired genomic rearrangements that activated NF-κB and PI3K-AKT signalling pathways, which promoted cell proliferation and survival, progressively inducing the formation of clonal B-cell lymphomas.